Source: Molecular Cytogenetics. Unidade: FMRP
Subjects: NEOPLASIAS, EPIGÊNESE GENÉTICA, PRÓSTATA, GENÔMICA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUTRA, William Lautert et al. Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer. Molecular Cytogenetics, v. 17, n. 1, p. 1-19, 2024Tradução . . Disponível em: https://doi.org/10.1186/s13039-024-00680-6. Acesso em: 25 fev. 2026.APA
Dutra, W. L., Melo, C. M., Chaves, L. P., Crozier, C., Saggioro, F. P., Reis, R. B. dos, et al. (2024). Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer. Molecular Cytogenetics, 17( 1), 1-19. doi:10.1186/s13039-024-00680-6NLM
Dutra WL, Melo CM, Chaves LP, Crozier C, Saggioro FP, Reis RB dos, Bayani J, Bonatto SL, Squire JA. Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer [Internet]. Molecular Cytogenetics. 2024 ; 17( 1): 1-19.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1186/s13039-024-00680-6Vancouver
Dutra WL, Melo CM, Chaves LP, Crozier C, Saggioro FP, Reis RB dos, Bayani J, Bonatto SL, Squire JA. Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer [Internet]. Molecular Cytogenetics. 2024 ; 17( 1): 1-19.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1186/s13039-024-00680-6
